PREPrenetics Global Limited
$17.42+6.8% 1Y
$17.42
$11.7952 weeks$26.30
Is the price fair?
What PRE's price assumes
Prenetics Global Limited did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 2.62× revenue.
2.62
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 2.46
Price / book · as of 2026-Q1
- EV / sales
- 2.13
EV / sales
Details›
- Price / bookas of 2026-Q1
- 2.46
- EV / EBIToperating margin −48%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q1
- 2.13
- Market capitalisation22.5 million shares, counted Dec 31, 2025
- $392M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Diagnostics & Research
Ranks #19 of 21 by RyuScore